What are the recent trends in market size and growth for the polymerase chain reactions (pcr) devices, reagents and uses market?
The polymerase chain reactions (PCR) devices, reagents and uses market size has grown strongly in recent years. It will grow from $6.19 billion in 2024 to $6.51 billion in 2025 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to rising prevalence of infectious diseases, increasing demand for clinical diagnostic services, growing demand for personalized medicine, increasing adoption of PCR in research and development.
The polymerase chain reactions (PCR) devices, reagents and uses market size is expected to see strong growth in the next few years. It will grow to $9.01 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to COVID-19 and infectious disease monitoring, cancer diagnostics and liquid biopsies, agricultural and environmental applications, expansion of pharmacogenomics, genomic research advancements. Major trends in the forecast period include digital PCR, multiplex PCR, next-generation sequencing (NGS) integration, miniaturization and portable devices, AI and data analytics, automation, and robotics.
Get Your Free Sample of The Global Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2485&type=smp
How have varous drivers impacted the growth of the polymerase chain reactions (pcr) devices, reagents and uses market?
The growing prevalence of infectious diseases across the world is driving the polymerase chain reactions devices, reagents, and uses market. Polymerase chain reaction devices are used in clinical laboratories to detect the presence of infectious diseases. In a report published by the World Health Organization, it was reported that around 17 million people are killed in a year due to infectious diseases. Also, the same report stated that 30 new infectious diseases have emerged in the last 20 years. For instance, in August 2024, according to the UK Health Security Agency, a government agency in the United Kingdom, there were 368 measles cases in England in 2023, a near 7-fold increase compared to 2022 (when 53 cases were reported). Such instances are increasing the demand for clinical diagnostic services and thereby driving the polymerase chain reactions devices, reagents, and uses market.
What are the primary segments of the polymerase chain reactions (pcr) devices, reagents and uses market?
The polymerase chain reactions (PCR) devices, reagents and uses market covered in this report is segmented –
1) By Product: Instruments, Reagents, Consumables
2) By Instruments: Standard PCR, RT-PCR, Digital PCR
3) By End User: Pharmaceutical and biotechnology industries, Clinical Diagnostics labs and hospitals, Academics and research organization
Subsegments:
1) By Instruments: Thermal Cyclers, Real-Time PCR Systems, Digital PCR Systems
2) By Reagents: Master Mixes, Primers And Probes, Enzymes, Nucleotides
3) By Consumables: PCR Tubes, PCR Plates, Seals And Films, Pipette Tips
Order your report now for swift delivery
Which firms are leading the polymerase chain reactions (pcr) devices, reagents and uses market?
Major companies operating in the polymerase chain reactions (PCR) devices, reagents and uses market include Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Becton Dickinson and Company, Abbott Laboratories, bioMérieux S.A., Agilent Technologies Inc., QIAGEN N.V., Siemens Healthcare GmbH (Siemens AG), Fluidigm Corporation, SYGNIS Pharma AG, Takara Bio Inc., Cepheid, Lontech Laboratories, Eppendorf India Private Limited, GE Healthcare, Kapa Biosystems, Maxim Biomedical Inc., Promega Corporation, RainDance Technologies Inc., Affymetrix Inc., Beckman Coulter Inc., Enzo Life Sciences Inc., Roche Diagnostics GmbH, Merck KGaA, Danaher Corporation, Stilla Technologies, Meridian Bioscience Inc., BioFire Diagnostics LLC, Luminex Corporation, GenMark Diagnostics Inc.
How will evolving trends contribute to the growth of the polymerase chain reactions (pcr) devices, reagents and uses market?
The emergence of alternatives is a major restraint on the growth of polymerase chain reaction devices and the reagents market. In the field of DNA sequencing, the polymerase chain reaction technique has competitors like Next Generation Sequencing and Sanger Sequencing which provide similar utility as PCR devices and reagents and even better results in some cases, thus increasing the competition in the market and thereby limiting PCR devices and reagents growth. For instance, in a study conducted, 138 FFPE non-small lung cancer samples were examined, with assays developed through Sanger, Next Generation Sequencing, and polymerase chain reaction techniques. All three assays were compared and it was reported that assays developed by NGS and QPCR exhibited similar analytical sensitivity, simplicity, and high level of concordance. Moreover, it was found that NGS assays proved to be better than qPCR in displaying more accurate information about allele sequence, mutation frequency, and the detection of non-hotspot mutations. This emergence of alternative procedures is expected to restrain the growth of the market during the forecast period.
How do regional factors impact the polymerase chain reactions (pcr) devices, reagents and uses market, and which region is the largest contributor?
North America was the largest region in the polymerase chain reactions (PCR) devices and reagents market in 2024. Western Europe was the second-largest region in the global polymerase chain reactions (PCR) devices and reagents market report. The regions covered in the polymerase chain reactions (PCR) devices, reagents and uses market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
What Does The Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Report 2025 Offer?
The polymerase chain reactions (pcr) devices, reagents and uses market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Polymerase Chain Reaction (PCR) devices and reagents are designed to aid scientists in producing multiple copies of specific DNA segments. In PCR, a section of the genome to be amplified is chosen using short synthetic DNA fragments called primers, and the segment is subsequently amplified through numerous rounds of DNA synthesis.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2485
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
